Topas Therapeutics GMBH

Recently troubled First Wave BioPharma, Inc. is adding pipeline and clinical development capability in an all-stock merger with privately held ImmunogenX , a deal announced on 18 December that will

Timm Jessen was previously chief scientific officer at Evotec AG before founding Topas Therapeutics GMBH ; he chats to Scrip on the sidelines of the recent BIO-Europe partnering meeting about

IN VITRO DIAGNOSTICS Financings Cancer Genetics Inc. Molecular diagnostics firm Cancer Genetics Inc. entered a financing agreement with Aspire Capital, through which Aspire will purchase, over the

Just under a year and a half after being spun off from Evotec AG , Germany's Topas Therapeutics GMBH has signed a deal with Eli Lilly & Co. in the field of antigen-specific tolerance induct